Kite Lake Capital Management (UK) LLP

13F Portfolio Filings

Most recent 13F
Q4 2023
Location
London, United Kingdom
CIK
0001687444
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2023 5 125,609 UBSG.SW calls, UBSG.SW, IAU.TO, BA puts 13F-HR 2/13/2024 000091957424001182
Q3 2023 6 86,696 UBSG.SW calls, UBSG.SW, IAU.TO, BA puts 13F-HR 11/13/2023 000091957423006204
Q2 2023 5 44,472 UBSG.SW, SDRL.OL, IAU.TO, NE 13F-HR 8/14/2023 000091957423004658
Q1 2023 9 93,528 ODP, NATI, SPWH, UBSG.SW 13F-HR 5/15/2023 000091957423003184
Q4 2022 9 121,112 ODP, ROG, SPWH, IAU.TO 13F-HR 2/13/2023 000091957423001301
Q3 2022 8 99,569 ODP, NE, SPWH, ATCO 13F-HR 11/10/2022 000091957422006389
Q2 2022 7 90,439 ODP, SPWH, NE, VAL 13F-HR 8/15/2022 000091957422004878
Q1 2022 6 129,052 ODP, SPWH, NE, DO 13F-HR 5/16/2022 000091957422003404
Q4 2021 12 425,846 NUAN, VG, AMD calls, VNE NEW HOLDINGS 12/21/2022 000091957422007144
Q4 2021 4 90,801 ODP, SPWH, NE, MX 13F-HR 2/14/2022 000091957422001333
Q3 2021 7 90,989 NE, ODP, VAL, FLOW 13F-HR 11/15/2021 000091957421007109
Q2 2021 2 31,479 ODP, ATC 13F-HR 8/16/2021 000091957421005346
Q1 2021 5 155,681 CLGX, QGEN calls, ODP, FFG 13F-HR 5/17/2021 000091957421003684
Q4 2020 5 120,771 CLGX, QGEN calls, FFG, AEL calls 13F-HR 2/16/2021 000091957421001255
Q3 2020 9 100,013 CHINA BIOLOGIC PRODS HLDGS I, CLGX, NAV, PACB 13F-HR 11/16/2020 000091957420007055
Q2 2020 8 64,289 CHINA BIOLOGIC PRODS HLDGS I, PACB, NAVISTAR INTL CORP, BRISTOL-MYERS SQUIBB CO 13F-HR 8/14/2020 000091957420005237
Q1 2020 7 62,659 CHINA BIOLOGIC PRODS HLDGS I, PACB, QGEN calls, BRISTOL-MYERS SQUIBB CO 13F-HR 5/15/2020 000091957420003537
Q4 2019 3 31,565 CHINA BIOLOGIC PRODS HLDGS I, QGEN, BRISTOL MYERS SQUIBB CO RESTATEMENT 3/10/2020 000091957420002265
Q3 2019 6 188,332 WBC, ONCE, VSM, PACB NEW HOLDINGS 3/10/2020 000091957420002264
Q3 2019 2 1,222,656 SPY puts, CHINA BIOLOGIC PRODS HLDGS I 13F-HR 11/14/2019 000091957419007173
Q2 2019 8 345,656 RHT, WBC, ARRY, ONCE NEW HOLDINGS 3/10/2020 000091957420002263
Q2 2019 3 1,571,426 SPY puts, BA puts, TRCO 13F-HR 8/14/2019 000091957419005247
Q1 2019 9 349,207 BMY, RHT, CELG, WBC NEW HOLDINGS 3/10/2020 000091957420002262
Q1 2019 4 1,201,932 SPY puts, BA puts, TRCO, FOXA 13F-HR 5/15/2019 000091957419003582
Q4 2018 5 136,188 IDTI, RHT, USG, TFCF NEW HOLDINGS 3/10/2020 000091957420002261
Q4 2018 7 176,655 NSU, TRCO, SPY puts, NXSTAGE MEDICAL INC 13F-HR 2/13/2019 000091957419001083
Q3 2018 10 153,047 SODA, PX, USG, IDTI NEW HOLDINGS 3/10/2020 000091957420002260
Q3 2018 10 330,466 SPY puts, NSU, NXSTAGE MEDICAL INC, NXPI 13F-HR 11/13/2018 000091957418007114
Q2 2018 8 92,624 USG, ENVISION HEALTHCARE CORP, KLXI, TFCF NEW HOLDINGS 3/10/2020 000091957420002259
Q2 2018 9 195,510 NXPI, XL GROUP LTD, AET, NXSTAGE MEDICAL INC 13F-HR 8/14/2018 000091957418005534
Q1 2018 15 624,233 SPY puts, NXPI, MON, TWX calls 13F-HR 5/15/2018 000091957418003728
Q4 2017 13 849,268 SPY puts, NXPI, TWX, CALPINE CORP 13F-HR 3/20/2018 000091957418002567
Additional filings from Kite Lake Capital Management (UK) LLP that have since been restated